STOCK TITAN

[SCHEDULE 13G/A] PetVivo Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

A.L. Sarroff Fund, LLC filed Amendment No. 10 to Schedule 13G reporting beneficial ownership of 8,846,288 shares of PetVivo Holdings, Inc. common stock, representing 31.7% of the class. The filer reports sole voting and sole dispositive power over the same 8,846,288 shares, with no shared power.

The filing states reliance on Rule 13d-1(c) and certifies the securities were not acquired to change or influence control. It also discloses 4,780,008 warrants with specified future exercisability dates that are not included in the Schedule 13G ownership per Rule 13d-3(d)(1). As context, the issuer had 27,903,361 shares outstanding as of August 14, 2025, and the filer notes its holdings were 26.5% as of June 30, 2025.

Positive
  • None.
Negative
  • None.

Insights

Large passive stake disclosed with full voting power; warrants excluded.

A.L. Sarroff Fund, LLC reports beneficial ownership of 8,846,288 shares of PetVivo, or 31.7%, with sole voting and dispositive power over that amount. The filer relies on Rule 13d-1(c), which is used for passive investors, and includes the standard certification regarding non-control intent.

The filing lists 4,780,008 warrants with exercisability dates on Aug 11, 2026, Dec 15, 2026, Apr 29, 2027, May 15, 2027, and Jul 9, 2027. Per Rule 13d-3(d)(1), these are not counted in the reported 13G ownership. As a reference point, PetVivo reported 27,903,361 shares outstanding as of Aug 14, 2025.

Stake concentration is high by percentage, but the filing itself does not describe any control-seeking purpose. Actual impact depends on future disclosures and any changes in reported ownership or warrant exercises.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: [1] A.L. Sarroff Fund, LLC (the "Company") is a New York Limited Liability Company (LLC) whose two individual members own, respectively, 90% and 10% of the Company's membership interests. The securities reported in this Schedule 13G were acquired primarily in accounts in the name of the Company and partly in accounts in the names of the two individual members. [2] In addition to the common shares reported in this Schedule 13G, the Company owns and/or controls 4,780,008 Warrants of the issuer. The Warrants are exercisable on the following schedule: $1,166,800.00 exercisable as of August 11, 2026, 111,112 exercisable as of December 15, 2026, 859,370 exercisable as of April 29, 2027, 142,858 exercisable as of May 15, 2027, and 2,500,000.00 exercisable as of July 9, 2027. These Warrants have not been exercised. Pursuant to SEC Rule 13d-3(d) (1), these Warrants are therefore not included in the Company's aggregate shareholdings for purposes of this Schedule G. [3] According to the issuer's latest Form 10-Q, there were 27,903,361 outstanding common shares as of August 14, 2025. The common shares owned and/or controlled by the Company as of June 30, 2025 totaled 26.5% of the common shares outstanding. [4] This filing is made in reliance upon SEC Rule 13d-1(c). The Company, (a) has not acquired the securities with any purpose, or with the effect, of changing or influencing the control of the issuer, or in connection with or as a participant in any transaction having that purpose or effect, including any transaction subject to Rule 13d-3(b); (b) is not a person reporting pursuant to SEC Rule 13d-1(b)(1); and (c) is not directly or indirectly the beneficial owner of 20 percent of more of the class.


SCHEDULE 13G



A.L. Sarroff Fund, LLC
Signature:Alan L. Sarroff
Name/Title:Alan L. Sarroff, Chief Executive Officer and Managing Member
Date:10/30/2025

FAQ

What stake in PETV did A.L. Sarroff Fund report?

The filer reported 8,846,288 shares, representing 31.7% of PetVivo Holdings, Inc. common stock.

Does A.L. Sarroff Fund have voting control over its PETV shares?

The filing reports sole voting power and sole dispositive power over 8,846,288 shares, with no shared power.

Were any PETV warrants disclosed in the filing?

Yes. The filer disclosed 4,780,008 warrants with future exercisability dates; these are not included in 13G ownership per Rule 13d-3(d)(1).

Under which rule was the PETV ownership reported?

The Schedule 13G/A was filed in reliance on Rule 13d-1(c) with a certification of non-control intent.

How many PETV shares were outstanding for context?

The issuer reported 27,903,361 shares outstanding as of August 14, 2025 in its latest Form 10-Q, as cited in the filing.

Did the filing note prior ownership context for PETV?

Yes. It states the fund’s common shares were 26.5% of outstanding as of June 30, 2025.
Petvivo Hldgs Inc

OTC:PETV

PETV Rankings

PETV Latest News

PETV Latest SEC Filings

PETV Stock Data

24.25M
12.40M
41.1%
0.77%
Medical Devices
Healthcare
Link
United States
Edina